David Montefiori

发表

Prediction of VRC01 neutralization sensitivity by HIV-1 gp160 sequence features

Marco Carone, Noah Simon, Craig A Magaret, 2019, PLoS Comput. Biol..

High Specific Infectivity of Plasma Virus from the Pre-Ramp-Up and Ramp-Up Stages of Acute Simian Immunodeficiency Virus Infection

Michael P. Busch, Mars Stone, David Montefiori, 2009, Journal of Virology.

Attenuated Poxvirus-Based Simian Immunodeficiency Virus (SIV) Vaccines Given in Infancy Partially Protect Infant and Juvenile Macaques Against Repeated Oral Challenge With Virulent SIV

Danielle Harvey, David Montefiori, P. Earl, 2005, Journal of acquired immune deficiency syndromes.

Antiviral Antibodies Are Necessary for Control of Simian Immunodeficiency Virus Replication

Jun Li, David Montefiori, Christopher J. Miller, 2007, Journal of Virology.

An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants

David Montefiori, John K. Rose, Douglas F. Nixon, 2001, Cell.

Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein.

David Montefiori, Guido Silvestri, D. Montefiori, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Limited ability of humoral immune responses in control of viremia during infection with SIVsmmD215 strain.

David Montefiori, Amitinder Kaur, D. Montefiori, 2009, Blood.

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.

Guido Ferrari, Sharon Frey, M Juliana McElrath, 2007, Vaccine.

Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state.

Jessica Yu, David Montefiori, Ellis L Reinherz, 2007, Vaccine.

Alphavirus Replicon Particles as Candidate HIV Vaccines

Philip R. Johnson, David Montefiori, Maureen F. Maughan, 2002, IUBMB life.

Design, Expression, and Immunogenicity of a Soluble HIV Trimeric Envelope Fragment Adopting a Prefusion gp41 Configuration*

Jia-huai Wang, David Montefiori, Ellis L Reinherz, 2005, Journal of Biological Chemistry.

Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial

Raphael Gottardo, Tomer Hertz, John Sidney, 2014, Journal of Virology.

Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody Responses

Barbra A. Richardson, David Anderson, David Montefiori, 2007, Journal of Virology.